Supplemental material
OncoImmunology
Volume 7, 2018 - Issue 7
Open access
5,450
Views
185
CrossRef citations to date
0
Altmetric
Original Research
CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial
Yao WangDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Meixia ChenDepartment of Bio-therapeutic, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Zhiqiang WuDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Chuan TongDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Hanren DaiDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Yelei GuoDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Yang LiuDepartment of Geriatric Hematology, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Jianhua HuangDepartment of Bio-therapeutic, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Haiyan LvDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Can LuoDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Kai-chao FengDepartment of Bio-therapeutic, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Qing-ming YangDepartment of Bio-therapeutic, Chinese PLA General Hospital, Beijing, ChinaView further author information
, Xiao-lei LiDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, ChinaView further author information
& Weidong HanDepartment of Molecular & Immunology, Chinese PLA General Hospital, Beijing, China;Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: e1440169
|
Received 19 Dec 2017, Accepted 06 Feb 2018, Published online: 07 May 2018
Related Research Data
The role of CD133 in cancer: a concise review
Source:
Wiley
An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity Against Colorectal Cancer
Source:
MDPI AG
Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
Source:
Springer Science and Business Media LLC
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Source:
Baishideng Publishing Group Inc.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.